Literature DB >> 30128588

Financial conflicts of interest in clinical research.

Jelena Savović1,2, Elie A Akl3,4, Asbjørn Hróbjartsson5,6,7.   

Abstract

Mesh:

Year:  2018        PMID: 30128588     DOI: 10.1007/s00134-018-5333-3

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  12 in total

1.  Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events?

Authors:  Bodil Als-Nielsen; Wendong Chen; Christian Gluud; Lise L Kjaergard
Journal:  JAMA       Date:  2003-08-20       Impact factor: 56.272

2.  Company stock prices before and after public announcements related to oncology drugs.

Authors:  Jeffrey M Rothenstein; George Tomlinson; Ian F Tannock; Allan S Detsky
Journal:  J Natl Cancer Inst       Date:  2011-09-26       Impact factor: 13.506

3.  Reporting and interpretation of randomized controlled trials with statistically nonsignificant results for primary outcomes.

Authors:  Isabelle Boutron; Susan Dutton; Philippe Ravaud; Douglas G Altman
Journal:  JAMA       Date:  2010-05-26       Impact factor: 56.272

4.  Accuracy of conflict-of-interest disclosures reported by physicians.

Authors:  Kanu Okike; Mininder S Kocher; Erin X Wei; Charles T Mehlman; Mohit Bhandari
Journal:  N Engl J Med       Date:  2009-10-08       Impact factor: 91.245

5.  Disclosure of conflicts of interest by authors of clinical trials and editorials in oncology.

Authors:  Rachel P Riechelmann; Lisa Wang; Aoife O'Carroll; Monika K Krzyzanowska
Journal:  J Clin Oncol       Date:  2007-10-10       Impact factor: 44.544

6.  Comparator bias: why comparisons must address genuine uncertainties.

Authors:  Howard Mann; Benjamin Djulbegovic
Journal:  J R Soc Med       Date:  2013-01       Impact factor: 5.344

7.  Selective publication of antidepressant trials and its influence on apparent efficacy.

Authors:  Erick H Turner; Annette M Matthews; Eftihia Linardatos; Robert A Tell; Robert Rosenthal
Journal:  N Engl J Med       Date:  2008-01-17       Impact factor: 91.245

Review 8.  Industry sponsorship and research outcome.

Authors:  Andreas Lundh; Joel Lexchin; Barbara Mintzes; Jeppe B Schroll; Lisa Bero
Journal:  Cochrane Database Syst Rev       Date:  2017-02-16

9.  Restoring Study 329: efficacy and harms of paroxetine and imipramine in treatment of major depression in adolescence.

Authors:  Joanna Le Noury; John M Nardo; David Healy; Jon Jureidini; Melissa Raven; Catalin Tufanaru; Elia Abi-Jaoude
Journal:  BMJ       Date:  2015-09-16

10.  Financial ties of principal investigators and randomized controlled trial outcomes: cross sectional study.

Authors:  Rosa Ahn; Alexandra Woodbridge; Ann Abraham; Susan Saba; Deborah Korenstein; Erin Madden; W John Boscardin; Salomeh Keyhani
Journal:  BMJ       Date:  2017-01-17
View more
  4 in total

Review 1.  Vitamin D supplementation for chronic liver diseases in adults.

Authors:  Milica Bjelakovic; Dimitrinka Nikolova; Goran Bjelakovic; Christian Gluud
Journal:  Cochrane Database Syst Rev       Date:  2021-08-25

2.  Nonalcoholic Steatohepatitis, Peroxisome Proliferator-Activated Receptors and Our Good Glitazar: Proof of the Pudding is in the Eating.

Authors:  Anil C Anand; Subrata K Acharya
Journal:  J Clin Exp Hepatol       Date:  2022-01-25

3.  Ivy leaf (Hedera helix) for acute upper respiratory tract infections: an updated systematic review.

Authors:  Elizabeth Sierocinski; Felix Holzinger; Jean-François Chenot
Journal:  Eur J Clin Pharmacol       Date:  2021-02-01       Impact factor: 2.953

Review 4.  Critical Analysis of a Randomized Controlled Trial.

Authors:  Balkrishna D Nimavat; Kapil G Zirpe; Sushma K Gurav
Journal:  Indian J Crit Care Med       Date:  2020-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.